Literature DB >> 4917090

Molindone in chronic schizophrenia.

M L Clark, W K Huber, K Sakata, D C Fowles, E A Serafetinides.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4917090     DOI： 10.1002/cpt1970115680

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

2.  Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.

Authors:  M H Makman; B Dvorkin; P N Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

3.  Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.

Authors:  A V Juorio
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

Review 4.  Zuclopenthixol versus placebo for schizophrenia.

Authors:  Michael Lacey; Mahesh B Jayaram
Journal:  Cochrane Database Syst Rev       Date:  2015-12-01

5.  Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.

Authors:  Maria S Neumeier; Stephanie Homan; Stefan Vetter; Erich Seifritz; John M Kane; Maximilian Huhn; Stefan Leucht; Philipp Homan
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.